Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)
Palestine
· Delayed Price · Currency is JOD · Price in USD 4.650
0.00 (0.00%)
At close: Mar 4, 2026
Jerusalem Pharmaceuticals Ratios and Metrics
Market cap in millions JOD. Fiscal year is January - December.
Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 59 | 59 | 49 | 49 | 42 | 36 | Upgrade
|
| Market Cap Growth | 30.07% | 20.04% | 0.69% | 15.82% | 16.13% | 2.15% | Upgrade
|
| Enterprise Value | 46 | 53 | 43 | 41 | 39 | 37 | Upgrade
|
| Last Close Price | 3.30 | 3.26 | 2.66 | 2.57 | 2.14 | 1.77 | Upgrade
|
| PE Ratio | 8.19 | 8.09 | 13.68 | 9.83 | 8.23 | 7.72 | Upgrade
|
| PS Ratio | 1.68 | 1.66 | 1.73 | 1.73 | 1.28 | 1.10 | Upgrade
|
| PB Ratio | 0.95 | 0.94 | 0.96 | 0.99 | 0.91 | 0.74 | Upgrade
|
| P/TBV Ratio | 0.99 | 0.98 | 1.00 | 1.03 | 0.94 | 0.80 | Upgrade
|
| P/FCF Ratio | 56.38 | 55.79 | 6.94 | 8.72 | 3.62 | 13.20 | Upgrade
|
| P/OCF Ratio | 23.64 | 23.39 | 5.87 | 7.44 | 3.47 | 8.42 | Upgrade
|
| EV/Sales Ratio | 1.29 | 1.50 | 1.52 | 1.47 | 1.18 | 1.12 | Upgrade
|
| EV/EBITDA Ratio | 4.28 | 5.06 | 7.64 | 5.73 | 5.19 | 5.20 | Upgrade
|
| EV/EBIT Ratio | 4.98 | 5.79 | 9.05 | 6.49 | 6.20 | 6.48 | Upgrade
|
| EV/FCF Ratio | 43.28 | 50.29 | 6.10 | 7.44 | 3.35 | 13.40 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.04 | 0.03 | 0.04 | Upgrade
|
| Debt / EBITDA Ratio | 0.09 | 0.09 | 0.18 | 0.23 | 0.20 | 0.25 | Upgrade
|
| Debt / FCF Ratio | 0.89 | 0.89 | 0.15 | 0.32 | 0.13 | 0.68 | Upgrade
|
| Net Debt / Equity Ratio | -0.23 | -0.23 | -0.14 | -0.06 | -0.09 | -0.04 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.39 | -1.39 | -1.30 | -0.41 | -0.53 | -0.29 | Upgrade
|
| Net Debt / FCF Ratio | -13.83 | -13.83 | -1.04 | -0.53 | -0.34 | -0.74 | Upgrade
|
| Asset Turnover | 0.50 | 0.50 | 0.45 | 0.47 | 0.54 | 0.56 | Upgrade
|
| Inventory Turnover | 2.11 | 2.11 | 2.10 | 1.72 | 1.79 | 1.61 | Upgrade
|
| Quick Ratio | 3.36 | 3.36 | 3.34 | 2.97 | 2.88 | 2.80 | Upgrade
|
| Current Ratio | 4.27 | 4.27 | 4.29 | 4.11 | 3.86 | 4.25 | Upgrade
|
| Return on Equity (ROE) | 12.90% | 12.90% | 7.21% | 10.45% | 10.77% | 9.55% | Upgrade
|
| Return on Assets (ROA) | 7.99% | 7.99% | 4.77% | 6.60% | 6.45% | 6.06% | Upgrade
|
| Return on Invested Capital (ROIC) | 14.42% | 15.82% | 8.14% | 11.48% | 11.22% | 10.07% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.50% | 13.50% | 8.70% | 12.10% | 12.60% | 10.80% | Upgrade
|
| Earnings Yield | 12.23% | 12.36% | 7.31% | 10.17% | 12.15% | 12.95% | Upgrade
|
| FCF Yield | 1.77% | 1.79% | 14.42% | 11.46% | 27.64% | 7.58% | Upgrade
|
| Dividend Yield | 1.72% | - | 2.14% | 2.76% | 4.98% | 4.80% | Upgrade
|
| Payout Ratio | 8.01% | 8.01% | 33.52% | 36.63% | 29.90% | 20.25% | Upgrade
|
| Buyback Yield / Dilution | -0.08% | -0.08% | - | - | - | - | Upgrade
|
| Total Shareholder Return | 1.64% | -0.08% | 2.14% | 2.76% | 4.98% | 4.80% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.